These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 16322331

  • 1. Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.
    Wagner K, Hemminki K, Israelsson E, Grzybowska E, Klaes R, Chen B, Butkiewicz D, Pamula J, Pekala W, Försti A.
    Endocr Relat Cancer; 2005 Dec; 12(4):917-28. PubMed ID: 16322331
    [Abstract] [Full Text] [Related]

  • 2. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
    Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC.
    J Natl Cancer Inst; 2005 Jan 05; 97(1):51-9. PubMed ID: 15632380
    [Abstract] [Full Text] [Related]

  • 3. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W, Kang D, Lee JE, Park IA, Choi JY, Lee KM, Bae JY, Kim S, Shin ES, Lee JE, Shin HJ, Kim SW, Kim SW, Noh DY.
    Clin Cancer Res; 2005 Jul 01; 11(13):4775-8. PubMed ID: 16000574
    [Abstract] [Full Text] [Related]

  • 4. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z, Cai Q, Shu XO, Cai H, Li C, Yu H, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 01; 13(8):1290-5. PubMed ID: 15298948
    [Abstract] [Full Text] [Related]

  • 5. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer.
    Wagner K, Hemminki K, Israelsson E, Grzybowska E, Söderberg M, Pamula J, Pekala W, Zientek H, Mielzynska D, Siwinska E, Försti A.
    Breast Cancer Res Treat; 2005 Jul 01; 92(2):133-40. PubMed ID: 15986122
    [Abstract] [Full Text] [Related]

  • 6. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese.
    Wong HL, Delellis K, Probst-Hensch N, Koh WP, Van Den Berg D, Lee HP, Yu MC, Ingles SA.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan 01; 14(1):144-51. PubMed ID: 15668488
    [Abstract] [Full Text] [Related]

  • 7. Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer.
    Vaclavicek A, Bermejo JL, Schmutzler RK, Sutter C, Wappenschmidt B, Meindl A, Kiechle M, Arnold N, Weber BH, Niederacher D, Burwinkel B, Bartram CR, Hemminki K, Försti A.
    Endocr Relat Cancer; 2007 Jun 01; 14(2):267-77. PubMed ID: 17639043
    [Abstract] [Full Text] [Related]

  • 8. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
    Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D, Hirschhorn J, Henderson BE.
    Hum Mol Genet; 2003 Oct 15; 12(20):2679-92. PubMed ID: 12944421
    [Abstract] [Full Text] [Related]

  • 9. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
    Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K.
    Cancer Res; 2004 Dec 15; 64(24):8891-900. PubMed ID: 15604249
    [Abstract] [Full Text] [Related]

  • 10. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
    Pechlivanis S, Wagner K, Chang-Claude J, Hoffmeister M, Brenner H, Försti A.
    Cancer Detect Prev; 2007 Dec 15; 31(5):408-16. PubMed ID: 18031946
    [Abstract] [Full Text] [Related]

  • 11. COX-2 gene promoter haplotypes and prostate cancer risk.
    Panguluri RC, Long LO, Chen W, Wang S, Coulibaly A, Ukoli F, Jackson A, Weinrich S, Ahaghotu C, Isaacs W, Kittles RA.
    Carcinogenesis; 2004 Jun 15; 25(6):961-6. PubMed ID: 14754878
    [Abstract] [Full Text] [Related]

  • 12. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
    Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA, Luccarini C, Munday H, Perkins B, Smith P, Pharoah PD, Wareham NJ, Easton DF, Ponder BA, Dunning AM.
    Hum Mol Genet; 2006 Jan 01; 15(1):1-10. PubMed ID: 16306136
    [Abstract] [Full Text] [Related]

  • 13. SNPs in ultraconserved elements and familial breast cancer risk.
    Yang R, Frank B, Hemminki K, Bartram CR, Wappenschmidt B, Sutter C, Kiechle M, Bugert P, Schmutzler RK, Arnold N, Weber BH, Niederacher D, Meindl A, Burwinkel B.
    Carcinogenesis; 2008 Feb 01; 29(2):351-5. PubMed ID: 18174240
    [Abstract] [Full Text] [Related]

  • 14. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.
    Breast Cancer Res Treat; 2007 Jan 01; 101(1):73-81. PubMed ID: 16807674
    [Abstract] [Full Text] [Related]

  • 15. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
    Johnatty SE, Spurdle AB, Beesley J, Chen X, Hopper JL, Duffy DL, Chenevix-Trench G, Kathleen Cuningham Consortium for Research in Familial Breast Cancer.
    Breast Cancer Res Treat; 2008 May 01; 109(1):91-9. PubMed ID: 17592773
    [Abstract] [Full Text] [Related]

  • 16. Pituitary growth hormone and growth hormone-releasing hormone receptor genes and associations with mammographic measures and serum growth hormone.
    Mulhall C, Hegele RA, Cao H, Tritchler D, Yaffe M, Boyd NF.
    Cancer Epidemiol Biomarkers Prev; 2005 Nov 01; 14(11 Pt 1):2648-54. PubMed ID: 16284391
    [Abstract] [Full Text] [Related]

  • 17. Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort.
    Freedman ML, Penney KL, Stram DO, Le Marchand L, Hirschhorn JN, Kolonel LN, Altshuler D, Henderson BE, Haiman CA.
    Hum Mol Genet; 2004 Oct 15; 13(20):2431-41. PubMed ID: 15317758
    [Abstract] [Full Text] [Related]

  • 18. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
    Choi JY, Lee KM, Park SK, Noh DY, Ahn SH, Chung HW, Han W, Kim JS, Shin SG, Jang IJ, Yoo KY, Hirvonen A, Kang D.
    Cancer Epidemiol Biomarkers Prev; 2005 May 15; 14(5):1090-5. PubMed ID: 15894657
    [Abstract] [Full Text] [Related]

  • 19. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
    Park JY, Park JM, Jang JS, Choi JE, Kim KM, Cha SI, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Lee JT, Jung TH.
    Hum Mol Genet; 2006 Jun 15; 15(12):1963-71. PubMed ID: 16687442
    [Abstract] [Full Text] [Related]

  • 20. The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development.
    Wagner K, Hemminki K, Försti A.
    Breast Cancer Res Treat; 2007 Sep 15; 104(3):233-48. PubMed ID: 17082888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.